The US Food and Drug Administration (FDA) has approved the first-ever CRISPR gene editing therapy, marking a significant breakthrough in medical science. This treatment, called "Zynteglo," can cure the rare blood disorder beta-thalassemia by altering patients' DNA. #US #FDA #DNA